Wikidata

(Q40742310)

English

P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel

scientific article published on February 2002

In more languages

Statements

title
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
author name string
Yoshimitsu Kimura
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
Jun Aoki
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
Masayuki Kohno
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
Hisayoshi Ooka
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
Takashi Tsuruo
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
Osamu Nakanishi
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
publication date
1 February 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017
page(s)
322-328
1 reference
stated in
Europe PubMed Central
PubMed ID
11914912
retrieved
23 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40742310&oldid=1906322180"